Genome-wide association studies (GWAS) have uncovered robust and reproducible links between polymorphisms in PNPLA3, TM6SF2, MBOAT7, GCKR, HSD17B13 and NAFLD pathogenesis [14, 15]. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.